AU7701098A - Laft mutants of pathogenic gram-negative bacteria - Google Patents

Laft mutants of pathogenic gram-negative bacteria

Info

Publication number
AU7701098A
AU7701098A AU77010/98A AU7701098A AU7701098A AU 7701098 A AU7701098 A AU 7701098A AU 77010/98 A AU77010/98 A AU 77010/98A AU 7701098 A AU7701098 A AU 7701098A AU 7701098 A AU7701098 A AU 7701098A
Authority
AU
Australia
Prior art keywords
laft
mutants
negative bacteria
pathogenic gram
pathogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU77010/98A
Inventor
Michael A. Apicella
Bradford W Gibson
Wade A. Nichols
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Iowa Research Foundation UIRF
University of California
Original Assignee
WADE A NICHOLS
University of Iowa Research Foundation UIRF
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WADE A NICHOLS, University of Iowa Research Foundation UIRF, University of California filed Critical WADE A NICHOLS
Publication of AU7701098A publication Critical patent/AU7701098A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
AU77010/98A 1997-05-28 1998-05-28 Laft mutants of pathogenic gram-negative bacteria Abandoned AU7701098A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4779197P 1997-05-28 1997-05-28
US60047791 1997-05-28
PCT/US1998/010881 WO1998053851A1 (en) 1997-05-28 1998-05-28 Laft mutants of pathogenic gram-negative bacteria

Publications (1)

Publication Number Publication Date
AU7701098A true AU7701098A (en) 1998-12-30

Family

ID=21950999

Family Applications (1)

Application Number Title Priority Date Filing Date
AU77010/98A Abandoned AU7701098A (en) 1997-05-28 1998-05-28 Laft mutants of pathogenic gram-negative bacteria

Country Status (2)

Country Link
AU (1) AU7701098A (en)
WO (1) WO1998053851A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6685949B1 (en) 1998-01-13 2004-02-03 The United States Of America As Represented By The Department Of Health & Human Services Lipooligosaccharide based vaccine for prevention of moraxella (branhamella)catarrhalis infections in humans
CA2315746A1 (en) * 1998-01-13 1999-07-22 The Government Of The United States Of America Lipooligosaccharide-based vaccine for prevention of moraxella (branhamella) catarrhalis infections in mammals
US6531131B1 (en) 1999-08-10 2003-03-11 The United States Of America As Represented By The Department Of Health And Human Services Conjugate vaccine for Neisseria meningitidis
WO2006085910A2 (en) * 2004-06-04 2006-08-17 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Endotoxin-free moraxella catarrhalis
PT1984021T (en) 2006-01-19 2016-11-02 Res Corp Tech Inc Viable non-toxic gram negative bacteria
ES2383231T3 (en) 2007-10-19 2012-06-19 Novartis Ag Formulations for meningococcal vaccines
US20100189737A1 (en) 2008-12-17 2010-07-29 Arico Beatrice Meningococcal vaccines including hemoglobin receptor
CN104548082A (en) 2009-03-24 2015-04-29 诺华股份有限公司 Adjuvanting meningococcal factor H binding protein
BRPI1009829A2 (en) 2009-03-24 2016-11-16 Novartis Ag meningococcal h-factor binding protein combinations and pneumococcal saccharide conjugates
AU2010288239B2 (en) 2009-08-27 2014-01-16 Novartis Ag Adjuvant comprising aluminium, oligonucleotide and polycation
CA2791697C (en) 2010-03-12 2019-08-13 Research Corporation Technologies Viable gram negative bacteria lacking outer membrane agonists of tlr4/md-2
EP2547357A1 (en) 2010-03-18 2013-01-23 Novartis AG Adjuvanted vaccines for serogroup b meningococcus
CA2803239A1 (en) 2010-06-25 2011-12-29 Novartis Ag Combinations of meningococcal factor h binding proteins
AU2011384634A1 (en) 2011-12-29 2014-06-19 Novartis Ag Adjuvanted combinations of meningococcal factor H binding proteins
PT2941258T (en) 2013-01-02 2019-12-12 Decoy Biosystems Inc Compositions and methods for treatment of cancer using bacteria
WO2017201193A1 (en) * 2016-05-17 2017-11-23 Cornell University Compositions and methods for the expression of eukaryotic oligosaccharides on bacterial outer membrane vesicles

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE940698L (en) * 1984-04-05 1985-10-05 Univ Missouri Vaccine and serum for endotoxin associated disease and method of preparing same as well as to methods of immunization and treatment of such disease and to a detoxified endotoxin and bacterial mutant

Also Published As

Publication number Publication date
WO1998053851A1 (en) 1998-12-03

Similar Documents

Publication Publication Date Title
AU5426096A (en) Uses of antibacterial compounds
AU7483596A (en) Magnet
PL316633A1 (en) Cephalosporin antibiotics
AU1278995A (en) Pseudomonas biocontrol strains
AU7701098A (en) Laft mutants of pathogenic gram-negative bacteria
AUPN012594A0 (en) Strengthening of poles
AU685029B2 (en) Method of strengthening antibacterial action of antibiotics
AU5828996A (en) Shaft coupling
AU5818496A (en) Antibacterial cephalosporins
HK1017887A1 (en) Cephalosporin antibiotics
AU6053096A (en) Magnetic gap construction
AU5671998A (en) Novel microorganisms
EP0739983A3 (en) Gene encoding lacto-n-biosidase
AU4324397A (en) Detection of microorganisms
AU4715696A (en) Astaxanthin suspension
AUPP790698A0 (en) Separation of microorganisms
AU5698396A (en) Antibiotics
AUPM900894A0 (en) Bacterial xylanase
AU1307595A (en) Typing of microorganisms
AU1586295A (en) Modification of filamentous microorganisms
AUPM493594A0 (en) Bacterial xylanase
AU5985596A (en) Cephalosporin antibiotics
AU3177995A (en) Tribological arrangement
AU5840496A (en) Assay for microorganisms
AU7621796A (en) Axial sealing

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase